LA Capital EAFE Equity (S:0P00012O1F)
22.61
-1.89
(-7.72%)
USD |
Dec 31 2024
Returns Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Key Stats
Basic Info
| Investment Strategy | |
| None |
| General | |
| Security Type | None |
| Equity Style | None |
| Fixed Income Style | None |
| Broad Asset Class | None |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Fund Owner Firm Name | None |
| Broad Asset Class Benchmark Index | |
| None | |
Annual Total Returns Versus Peers
As of January 01, 2026.
Asset Allocation
| Type | % Net |
|---|---|
| Cash | -- |
| Stock | -- |
| Bond | -- |
| Convertible | -- |
| Preferred | -- |
| Other | -- |
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| Novartis AG | 2.13% | 138.00 | -0.32% |
| HSBC Holdings Plc | 1.89% | 15.70 | -1.41% |
| Intesa Sanpaolo SpA | 1.58% | 7.09 | 0.50% |
| Safran SA | 1.57% | 345.76 | -2.25% |
| Banco Bilbao Vizcaya Argentaria SA | 1.56% | 24.56 | 4.23% |
| AstraZeneca PLC | 1.53% | 175.50 | -2.96% |
| ASML Holding NV | 1.32% | 1065.00 | -2.63% |
| Deutsche Telekom AG | 1.32% | 33.23 | 4.69% |
| ABB Ltd. | 1.32% | 76.52 | 1.10% |
| Roche Holding AG | 1.28% | 412.92 | 2.68% |
Fees & Availability
| Fees | |
| Negotiable Fee | -- |
| Maximum Management Fee | -- |
| Prospectus Custodian Fee | -- |
| Purchase Details | |
| Open to New Investors | -- |
Basic Info
| Investment Strategy | |
| None |
| General | |
| Security Type | None |
| Equity Style | None |
| Fixed Income Style | None |
| Broad Asset Class | None |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Fund Owner Firm Name | None |
| Broad Asset Class Benchmark Index | |
| None | |
Fundamentals
| General | |
| Number of Holdings | -- |
| Stock | |
| Weighted Average PE Ratio | -- |
| Weighted Average Price to Sales Ratio | -- |
| Weighted Average Price to Book Ratio | -- |
| Weighted Median ROE | -- |
| Weighted Median ROA | -- |
| Number of Equity Holdings | -- |
Fund Details
| Key Dates | |
| Inception Date | -- |
| Attributes | |
| Socially Responsible Fund | -- |